BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31246594)

  • 1. Why treatment efficacy on breathlessness in laboratory but not daily life trials? The importance of standardized exertion.
    Ekström M
    Curr Opin Support Palliat Care; 2019 Sep; 13(3):179-183. PubMed ID: 31246594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardized measurement of breathlessness during exercise.
    Lewthwaite H; Koch EM; Tracey L; Jensen D
    Curr Opin Support Palliat Care; 2019 Sep; 13(3):152-160. PubMed ID: 31268873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of opioids on breathlessness and exercise capacity in chronic obstructive pulmonary disease. A systematic review.
    Ekström M; Nilsson F; Abernethy AA; Currow DC
    Ann Am Thorac Soc; 2015 Jul; 12(7):1079-92. PubMed ID: 25803110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the Dyspnea Exertion Scale of Breathlessness in People With Life-Limiting Illness.
    Sandberg J; Johnson MJ; Currow DC; Ekström M
    J Pain Symptom Manage; 2018 Sep; 56(3):430-435.e2. PubMed ID: 29753099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness.
    Barnes H; McDonald J; Smallwood N; Manser R
    Cochrane Database Syst Rev; 2016 Mar; 3(3):CD011008. PubMed ID: 27030166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to Assess Breathlessness in Chronic Obstructive Pulmonary Disease.
    Lewthwaite H; Jensen D; Ekström M
    Int J Chron Obstruct Pulmon Dis; 2021; 16():1581-1598. PubMed ID: 34113091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioids, Exertion, and Dyspnea: A Review of the Evidence.
    Johnson MJ; Hui D; Currow DC
    Am J Hosp Palliat Care; 2016 Mar; 33(2):194-200. PubMed ID: 25294225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of arterial oxygen desaturation on six minute walk distance, perceived effort, and perceived breathlessness in patients with airflow limitation.
    Mak VH; Bugler JR; Roberts CM; Spiro SG
    Thorax; 1993 Jan; 48(1):33-8. PubMed ID: 8434350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical utility of measures of breathlessness.
    Cullen DL; Rodak B
    Respir Care; 2002 Sep; 47(9):986-93. PubMed ID: 12188932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of short-acting opioids in the management of breathlessness: an evidence-based review.
    Hui D; Bruera E
    Curr Opin Support Palliat Care; 2020 Sep; 14(3):167-176. PubMed ID: 32701856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the exertion required to induce breathlessness in a population with advanced cancer: matching measures to the level of physical function.
    White KM; Agar MR; Currow DC
    BMC Palliat Care; 2019 Jan; 18(1):4. PubMed ID: 30630479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palliative oxygen for chronic breathlessness: what new evidence?
    Ahmadi Z; Currow DC; Ekström M
    Curr Opin Support Palliat Care; 2017 Sep; 11(3):159-164. PubMed ID: 28644301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tests to uncover and assess breathlessness: a proposed framework.
    Ekström M
    Curr Opin Support Palliat Care; 2022 Dec; 16(4):188-194. PubMed ID: 36165599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease.
    Marin JM; Carrizo SJ; Gascon M; Sanchez A; Gallego B; Celli BR
    Am J Respir Crit Care Med; 2001 May; 163(6):1395-9. PubMed ID: 11371407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences between experienced and recalled breathlessness: a review.
    Sandberg J; Ekström M
    Curr Opin Support Palliat Care; 2019 Sep; 13(3):161-166. PubMed ID: 31365460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the trajectory of exertional breathlessness on symptom recall and anticipation: A randomized controlled trial.
    Elmberg V; Ekström M
    PLoS One; 2020; 15(9):e0238937. PubMed ID: 32915891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dyspnoea with activities of daily living versus peak dyspnoea during exercise in male patients with COPD.
    Oga T; Nishimura K; Tsukino M; Hajiro T; Mishima M
    Respir Med; 2006 Jun; 100(6):965-71. PubMed ID: 16298519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on combined modalities for the management of breathlessness.
    Clemens KE; Faust M; Bruera E
    Curr Opin Support Palliat Care; 2012 Jun; 6(2):163-7. PubMed ID: 22469671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome measurement of refractory breathlessness: endpoints and important differences.
    Ekström M; Currow DC; Johnson MJ
    Curr Opin Support Palliat Care; 2015 Sep; 9(3):238-43. PubMed ID: 26203849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiologic responses to incremental and self-paced exercise in COPD: a comparison of three tests.
    Turner SE; Eastwood PR; Cecins NM; Hillman DR; Jenkins SC
    Chest; 2004 Sep; 126(3):766-73. PubMed ID: 15364755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.